Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.39 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.39 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | FABP3 | P05413 | 1/20 | 0.38 |
| ▸ | FABP4 | P15090 | 1/20 | 0.38 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29364414 | 0.76 | GPR3 (0.58) | GPR3CYP1A2CYP2C19KDM4EATM | |
| SCHEMBL10617464 | 0.76 | GPR3 (0.58) | GPR3CYP1A2CYP2C19KDM4EATM | |
| SCHEMBL11959493 | 0.73 | GPR3 (0.55) | GPR3CYP1A2CYP2C19KDM4EATM | |
| SCHEMBL3890065 | 0.71 | GPR3 (0.46) | GPR3CYP1A2CYP2C19KDM4EATM | |
| SCHEMBL29940205 | 0.71 | GPR3 (0.46) | GPR3CYP1A2CYP2C19KDM4EATM | |
| SCHEMBL32665750 | 0.71 | GPR3 (0.46) | GPR3CYP1A2CYP2C19KDM4EATM | |
| SCHEMBL7647965 | 0.71 | GPR3 (0.52) | GPR3CYP1A2CYP2C19KDM4EATM | |
| SCHEMBL18587181 | 0.71 | GPR3 (0.52) | GPR3CYP1A2CYP2C19KDM4EATM | |
| SCHEMBL13374381 | 0.71 | GPR3 (0.52) | GPR3CYP1A2CYP2C19KDM4EATM | |
| SCHEMBL29321 | 0.71 | GPR3 (1.00) | GPR3CYP1A2CYP2C19KDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080036373-A1 | Platinum complex and light-emitting device | TAKASAGO INTERNATIONAL CORPORATION | 2008-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080036373-A1 | Platinum complex and light-emitting device | XPA, ERCC4, UACA | GPR3 3058/4885CYP1A2 3095/4885CYP2C19 1871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.